Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhang Chen

Showing results (461-470 of 470) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 470 results.
Acta Pharmacologica Sinica|August 5, 2021
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike proteinLin Wang, Yan Wu, Sheng Yao, et al.
Annals of Neurology|April 5, 2014
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymiaYing-Zhang Chen, Jennifer R Friedman, Dong-Hui Chen, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
International Journal of Antimicrobial Agents|June 8, 2024
A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patientsYing Li, Demei Zhu, Shenghua Sun, et al.
Eclinicalmedicine|February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation studyJian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Hepatology International|October 21, 2023
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendationsMing Zhao, Zhi Guo, Ying-Hua Zou, et al.
Eclinicalmedicine|May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation studyZhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Scientific Data|February 11, 2023
The Psychological Science Accelerator's COVID-19 rapid-response datasetErin M Buchanan, Savannah C Lewis, Bastien Paris, et al.
Nature Human Behaviour|August 3, 2021
A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemicKe Wang, Amit Goldenberg, Charles A Dorison, et al.
Affective Science|October 3, 2022
In COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 CountriesCharles A Dorison, Jennifer S Lerner, Blake H Heller, et al.
Pageof 47

Showing results (461-470 of 470) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 470 results.
Acta Pharmacologica Sinica|August 5, 2021
Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike proteinLin Wang, Yan Wu, Sheng Yao, et al.
Annals of Neurology|April 5, 2014
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymiaYing-Zhang Chen, Jennifer R Friedman, Dong-Hui Chen, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
International Journal of Antimicrobial Agents|June 8, 2024
A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patientsYing Li, Demei Zhu, Shenghua Sun, et al.
Eclinicalmedicine|February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation studyJian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Hepatology International|October 21, 2023
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendationsMing Zhao, Zhi Guo, Ying-Hua Zou, et al.
Eclinicalmedicine|May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation studyZhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Scientific Data|February 11, 2023
The Psychological Science Accelerator's COVID-19 rapid-response datasetErin M Buchanan, Savannah C Lewis, Bastien Paris, et al.
Nature Human Behaviour|August 3, 2021
A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemicKe Wang, Amit Goldenberg, Charles A Dorison, et al.
Affective Science|October 3, 2022
In COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 CountriesCharles A Dorison, Jennifer S Lerner, Blake H Heller, et al.
Pageof 47